Filtros : "Nova Caledonia" "2017" Removidos: "MISOGUTI, LINO" "Ruffino, Sandra Fagionato" "VALIN, SIRLENE APARECIDA DE ALMEIDA" "PARTE DE MONOGRAFIA/LIVRO-TRADUCAO" Limpar

Filtros



Refine with date range


  • Source: Journal of Electroanalytical Chemistry. Unidade: IQSC

    Subjects: ELETRODEPOSIÇÃO, ELETRODO

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      MARTINS, Alysson Stefan e NUÑEZ, Luciana e LANZA, Marcos Roberto de Vasconcelos. Enhanced photoelectrocatalytic performance of TiO2 nanotube array modified with WO3 applied to the degradation of the endocrine disruptor propyl paraben. Journal of Electroanalytical Chemistry, v. 802, p. 33-39, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.jelechem.2017.08.040. Acesso em: 21 jul. 2024.
    • APA

      Martins, A. S., Nuñez, L., & Lanza, M. R. de V. (2017). Enhanced photoelectrocatalytic performance of TiO2 nanotube array modified with WO3 applied to the degradation of the endocrine disruptor propyl paraben. Journal of Electroanalytical Chemistry, 802, 33-39. doi:10.1016/j.jelechem.2017.08.040
    • NLM

      Martins AS, Nuñez L, Lanza MR de V. Enhanced photoelectrocatalytic performance of TiO2 nanotube array modified with WO3 applied to the degradation of the endocrine disruptor propyl paraben [Internet]. Journal of Electroanalytical Chemistry. 2017 ; 802 33-39.[citado 2024 jul. 21 ] Available from: https://doi.org/10.1016/j.jelechem.2017.08.040
    • Vancouver

      Martins AS, Nuñez L, Lanza MR de V. Enhanced photoelectrocatalytic performance of TiO2 nanotube array modified with WO3 applied to the degradation of the endocrine disruptor propyl paraben [Internet]. Journal of Electroanalytical Chemistry. 2017 ; 802 33-39.[citado 2024 jul. 21 ] Available from: https://doi.org/10.1016/j.jelechem.2017.08.040
  • Source: Journal of the neurological sciences. Unidade: IMT

    Subjects: INFECÇÕES POR HTLV-I, NEUROPSICOLOGIA, DEPRESSÃO

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      GASCÓN, Maria Rita Polo et al. Cognitive impairment is frequent among symptomatic carriers of human T-cell lymphotropic virus type 1 (HTLV-1), regardless of their clinical status. Journal of the neurological sciences, v. 377, p. 185-189, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.jns.2017.04.019. Acesso em: 21 jul. 2024.
    • APA

      Gascón, M. R. P., Casseb, J. S. do R., Smid, J., Vidal, J. E., Fonseca, L. A. M., Paiva, A., et al. (2017). Cognitive impairment is frequent among symptomatic carriers of human T-cell lymphotropic virus type 1 (HTLV-1), regardless of their clinical status. Journal of the neurological sciences, 377, 185-189. doi:10.1016/j.jns.2017.04.019
    • NLM

      Gascón MRP, Casseb JS do R, Smid J, Vidal JE, Fonseca LAM, Paiva A, Haziot MEJ, Oliveira ACP de. Cognitive impairment is frequent among symptomatic carriers of human T-cell lymphotropic virus type 1 (HTLV-1), regardless of their clinical status [Internet]. Journal of the neurological sciences. 2017 ; 377 185-189.[citado 2024 jul. 21 ] Available from: https://doi.org/10.1016/j.jns.2017.04.019
    • Vancouver

      Gascón MRP, Casseb JS do R, Smid J, Vidal JE, Fonseca LAM, Paiva A, Haziot MEJ, Oliveira ACP de. Cognitive impairment is frequent among symptomatic carriers of human T-cell lymphotropic virus type 1 (HTLV-1), regardless of their clinical status [Internet]. Journal of the neurological sciences. 2017 ; 377 185-189.[citado 2024 jul. 21 ] Available from: https://doi.org/10.1016/j.jns.2017.04.019
  • Source: Vaccine. Unidade: IMT

    Subjects: DENGUE, VACINAS, IMUNIDADE

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      MARTÍNEZ-VEGA, Ruth Aralí et al. ADE and dengue vaccination. Vaccine, v. 35, n. 32, p. 3910-3912, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.vaccine.2017.06.004. Acesso em: 21 jul. 2024.
    • APA

      Martínez-Vega, R. A., Carrasquila, G., Luna, E. J. de A., & Ramos-Castañeda, J. (2017). ADE and dengue vaccination. Vaccine, 35( 32), 3910-3912. doi:10.1016/j.vaccine.2017.06.004
    • NLM

      Martínez-Vega RA, Carrasquila G, Luna EJ de A, Ramos-Castañeda J. ADE and dengue vaccination [Internet]. Vaccine. 2017 ; 35( 32): 3910-3912.[citado 2024 jul. 21 ] Available from: https://doi.org/10.1016/j.vaccine.2017.06.004
    • Vancouver

      Martínez-Vega RA, Carrasquila G, Luna EJ de A, Ramos-Castañeda J. ADE and dengue vaccination [Internet]. Vaccine. 2017 ; 35( 32): 3910-3912.[citado 2024 jul. 21 ] Available from: https://doi.org/10.1016/j.vaccine.2017.06.004

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024